Medium materiality6/10
10X Genomics (TXG) PT Raised to $60 at Canaccord
Why it may matterVerify against the original reporting
buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Canaccord Genuity raises PT to $60; target $60; current price $52.03; priceChangeSinceSignal +$7.80.
- Target $60; price $52.03; +$7.80 since signal; Canaccord Buy
Key facts
- 01
Target: $60
- 02
Posted price: $52.03
- 03
Analyst firm: Canaccord Genuity
- 04
Analyst: Kyle Mikson
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.